OKYO Pharma (OKYO) Non-Current Assets (2021 - 2025)
OKYO Pharma (OKYO) reported Non-Current Assets of $1178.0 for Q3 2025, down 45.41% year-over-year from $2158.0 in Q3 2024, and down 42.11% quarter-over-quarter from $2035.0 in Q1 2025.
OKYO Pharma (OKYO) Non-Current Assets (2021 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has 5 years of Non-Current Assets data on file, last reported at $1178.0 in Q3 2025.
- Non-Current Assets for Q3 2025 came in at $1178.0, down 45.41% year-over-year; the trailing twelve-month figure through Sep 2025 was $1178.0 (down 45.41% YoY), and the FY2025 annual result was $2035.0, down 39.25% from the prior year.
- Non-Current Assets slipped to $1178.0 in Q3 2025 per OKYO's latest filing, from $2035.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $104636.0 in Q1 2021 and troughed at $1178.0 in Q3 2025.
- A 5-year average of $16367.2 and a median of $4245.0 in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets tumbled 95.01% in 2022, then jumped 38.11% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $104636.0 in 2021, then plunged by 95.01% to $5225.0 in 2022, then slipped by 1.63% to $5140.0 in 2023, then sank by 58.02% to $2158.0 in 2024, then tumbled by 45.41% to $1178.0 in 2025.
- Business Quant data shows OKYO's Non-Current Assets at $1178.0 in Q3 2025, $2035.0 in Q1 2025, and $2158.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 62,953.78 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 39.71 Mn |
| 10 | OKYO Pharma | 244.98 Mn | 240.76 Mn | - | 1,178.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,178.00 |
| Mar 31, 2025 | 2,035.00 |
| Sep 30, 2024 | 2,158.00 |
| Mar 31, 2024 | 3,350.00 |
| Sep 30, 2023 | 5,140.00 |
| Mar 31, 2023 | 7,216.00 |
| Mar 31, 2022 | 5,225.00 |
| Mar 31, 2021 | 104,636.00 |